Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL3128069 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
ALK receptor tyrosine kinase/ALK tyrosine kinase receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4247] [GtoPdb: 1839] [UniProtKB: Q9UM73] | ||||||||
ChEMBL | Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay | B | 9.7 | pKi | 0.2 | nM | Ki | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
ChEMBL | Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay | B | 9.7 | pKi | 0.2 | nM | Ki | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
ChEMBL | Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay | B | 10 | pKi | <0.1 | nM | Ki | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
ChEMBL | Inhibition of ALK-fusion driven cell proliferation in human NCI-H3122 cells harboring ALK G1269A mutant after 72 hrs by CellTiter Glo assay | F | 7.62 | pIC50 | 24 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
ChEMBL | Inhibition of ALK-fusion driven cell proliferation in human NCI-H3122 cells harboring ALK L1196M mutant after 72 hrs by CellTiter Glo assay | F | 7.68 | pIC50 | 21 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
ChEMBL | Inhibition of human EML4-fused ALK G1269A mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 8.05 | pIC50 | 9 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
ChEMBL | Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 8.18 | pIC50 | 6.6 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
ChEMBL | Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 8.18 | pIC50 | 6.6 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
ChEMBL | Inhibition of human EML4-fused ALK S1206Y mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 8.35 | pIC50 | 4.5 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
ChEMBL | Inhibition of human EML4-fused ALK L1152R mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 8.46 | pIC50 | 3.5 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
ChEMBL | Inhibition of ALK-fusion driven cell proliferation in human KARPAS299 cells after 72 hrs by CellTiter Glo assay | F | 8.77 | pIC50 | 1.7 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
ChEMBL | Inhibition of ALK-fusion driven cell proliferation in human NCI-H3122 cells after 72 hrs by CellTiter Glo assay | F | 8.89 | pIC50 | 1.3 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
ChEMBL | Inhibition of ALK L1196M mutant in mouse NIH-3T3 cells | B | 9.1 | pIC50 | 0.8 | nM | IC50 | J Med Chem (2019) 62: 10927-10954 [PMID:31419130] |
ChEMBL | Inhibition of human wild type EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA | B | 9.1 | pIC50 | 0.8 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
GtoPdb | - | - | 9.1 | pIC50 | 0.8 | nM | IC50 | J Med Chem (2014) 57: 1170-87 [PMID:24432909] |
ChEMBL | Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA | B | 9.12 | pIC50 | 0.76 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
ChEMBL | Inhibition of human EML4-fused ALK C1156Y mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 9.22 | pIC50 | 0.6 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
ChEMBL | Inhibition of ALK L1196M (unknown origin) | B | 9.7 | pIC50 | 0.2 | nM | IC50 | J Med Chem (2019) 62: 10927-10954 [PMID:31419130] |
ChEMBL | Inhibition of human EML4-fused ALK F1174L mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 9.7 | pIC50 | 0.2 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
ALK receptor tyrosine kinase/ALK tyrosine kinase receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5771] [GtoPdb: 1839] [UniProtKB: P97793] | ||||||||
ChEMBL | Inhibition of ALK in mouse NIH-3T3 cells | B | 9.1 | pIC50 | 0.8 | nM | IC50 | J Med Chem (2019) 62: 10927-10954 [PMID:31419130] |
protein tyrosine kinase 2/Focal adhesion kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2695] [GtoPdb: 2180] [UniProtKB: Q05397] | ||||||||
ChEMBL | Inhibition of PTK2 (unknown origin) using Km levels of ATP | B | 7.8 | pIC50 | 16 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
leukocyte receptor tyrosine kinase/Leukocyte tyrosine kinase receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5627] [GtoPdb: 1838] [UniProtKB: P29376] | ||||||||
ChEMBL | Inhibition of LTK (unknown origin) using Km levels of ATP | B | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
GtoPdb | - | - | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (2014) 57: 1170-87 [PMID:24432909] |
neurotrophic receptor tyrosine kinase 1/Nerve growth factor receptor Trk-A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2815] [GtoPdb: 1817] [UniProtKB: P04629] | ||||||||
ChEMBL | Inhibition of NTRK1 (unknown origin) using Km levels of ATP | B | 7.77 | pIC50 | 17 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
neurotrophic receptor tyrosine kinase 2/Neurotrophic tyrosine kinase receptor type 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4898] [GtoPdb: 1818] [UniProtKB: Q16620] | ||||||||
ChEMBL | Inhibition of NTRK2 (unknown origin) using Km levels of ATP | B | 8.4 | pIC50 | 4 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
GtoPdb | - | - | 8.4 | pIC50 | 4 | nM | IC50 | J Med Chem (2014) 57: 1170-87 [PMID:24432909] |
neurotrophic receptor tyrosine kinase 3/NT-3 growth factor receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5608] [GtoPdb: 1819] [UniProtKB: Q16288] | ||||||||
ChEMBL | Inhibition of NTRK3 (unknown origin) using Km levels of ATP | B | 7.74 | pIC50 | 18 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
protein tyrosine kinase 2 beta/Protein tyrosine kinase 2 beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5469] [GtoPdb: 2181] [UniProtKB: Q14289] | ||||||||
ChEMBL | Inhibition of PTK2B (unknown origin) using Km levels of ATP | B | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
c-ros oncogene 1, receptor tyrosine kinase/Proto-oncogene tyrosine-protein kinase ROS in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5568] [GtoPdb: 1840] [UniProtKB: P08922] | ||||||||
ChEMBL | Inhibition of ROS1 (unknown origin) by Pfizer mobility shift assay | B | 10.7 | pKi | 0.02 | nM | Ki | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
GtoPdb | Value calculated from tight-binding (Morrison) equation for competitive inhibitors tested in a Pfizer mobility shift assay. | - | 10.7 | pKi | 0.02 | nM | Ki | J Med Chem (2014) 57: 1170-87 [PMID:24432909] |
tyrosine kinase non receptor 2/Tyrosine kinase non-receptor protein 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4599] [GtoPdb: 2246] [UniProtKB: Q07912] | ||||||||
ChEMBL | Inhibition of TNK2 (unknown origin) using Km levels of ATP | B | 7.82 | pIC50 | 15 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
FER tyrosine kinase/Tyrosine-protein kinase FER in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3982] [GtoPdb: 2022] [UniProtKB: P16591] | ||||||||
ChEMBL | Inhibition of FER (unknown origin) using Km levels of ATP | B | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
GtoPdb | - | - | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (2014) 57: 1170-87 [PMID:24432909] |
FES proto-oncogene, tyrosine kinase/Tyrosine-protein kinase FES in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5455] [GtoPdb: 2023] [UniProtKB: P07332] | ||||||||
GtoPdb | - | - | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2014) 57: 1170-87 [PMID:24432909] |
ChEMBL | Inhibition of FES (unknown origin) using Km levels of ATP | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
Janus kinase 2/Tyrosine-protein kinase JAK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2971] [GtoPdb: 2048] [UniProtKB: O60674] | ||||||||
ChEMBL | Inhibition of JAK2 (unknown origin) using Km levels of ATP | B | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (2014) 57: 1170-1187 [PMID:24432909] |
mitogen-activated protein kinase kinase kinase 9 in Human [GtoPdb: 2084] [UniProtKB: P80192] | ||||||||
GtoPdb | - | - | 7.42 | pIC50 | 38 | nM | IC50 | J Med Chem (2018) 61: 8078-8087 [PMID:29863360] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]